Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial.

Oxid Med Cell Longev · 2022 · PMC8828344 · PMID 35154575

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Genotyping Genotyping performance manifests a significant trend of genotype 3a in both groups either the control or treated group with a slight frequency of 2b.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.